909 related articles for article (PubMed ID: 29221645)
1. Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial.
Lean ME; Leslie WS; Barnes AC; Brosnahan N; Thom G; McCombie L; Peters C; Zhyzhneuskaya S; Al-Mrabeh A; Hollingsworth KG; Rodrigues AM; Rehackova L; Adamson AJ; Sniehotta FF; Mathers JC; Ross HM; McIlvenna Y; Stefanetti R; Trenell M; Welsh P; Kean S; Ford I; McConnachie A; Sattar N; Taylor R
Lancet; 2018 Feb; 391(10120):541-551. PubMed ID: 29221645
[TBL] [Abstract][Full Text] [Related]
2. Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial.
Lean MEJ; Leslie WS; Barnes AC; Brosnahan N; Thom G; McCombie L; Peters C; Zhyzhneuskaya S; Al-Mrabeh A; Hollingsworth KG; Rodrigues AM; Rehackova L; Adamson AJ; Sniehotta FF; Mathers JC; Ross HM; McIlvenna Y; Welsh P; Kean S; Ford I; McConnachie A; Messow CM; Sattar N; Taylor R
Lancet Diabetes Endocrinol; 2019 May; 7(5):344-355. PubMed ID: 30852132
[TBL] [Abstract][Full Text] [Related]
3. Effect of intensive lifestyle intervention on bodyweight and glycaemia in early type 2 diabetes (DIADEM-I): an open-label, parallel-group, randomised controlled trial.
Taheri S; Zaghloul H; Chagoury O; Elhadad S; Ahmed SH; El Khatib N; Amona RA; El Nahas K; Suleiman N; Alnaama A; Al-Hamaq A; Charlson M; Wells MT; Al-Abdulla S; Abou-Samra AB
Lancet Diabetes Endocrinol; 2020 Jun; 8(6):477-489. PubMed ID: 32445735
[TBL] [Abstract][Full Text] [Related]
4. 5-year follow-up of the randomised Diabetes Remission Clinical Trial (DiRECT) of continued support for weight loss maintenance in the UK: an extension study.
Lean ME; Leslie WS; Barnes AC; Brosnahan N; Thom G; McCombie L; Kelly T; Irvine K; Peters C; Zhyzhneuskaya S; Hollingsworth KG; Adamson AJ; Sniehotta FF; Mathers JC; McIlvenna Y; Welsh P; McConnachie A; McIntosh A; Sattar N; Taylor R
Lancet Diabetes Endocrinol; 2024 Apr; 12(4):233-246. PubMed ID: 38423026
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of weight loss-induced remission in people with prediabetes: a post-hoc analysis of the randomised, controlled, multicentre Prediabetes Lifestyle Intervention Study (PLIS).
Sandforth A; von Schwartzenberg RJ; Arreola EV; Hanson RL; Sancar G; Katzenstein S; Lange K; Preißl H; Dreher SI; Weigert C; Wagner R; Kantartzis K; Machann J; Schick F; Lehmann R; Peter A; Katsouli N; Ntziachristos V; Dannecker C; Fritsche L; Perakakis N; Heni M; Nawroth PP; Kopf S; Pfeiffer AFH; Kabisch S; Stumvoll M; Schwarz PEH; Hauner H; Lechner A; Seissler J; Yurchenko I; Icks A; Solimena M; Häring HU; Szendroedi J; Schürmann A; de Angelis MH; Blüher M; Roden M; Bornstein SR; Stefan N; Fritsche A; Birkenfeld AL
Lancet Diabetes Endocrinol; 2023 Nov; 11(11):798-810. PubMed ID: 37769677
[TBL] [Abstract][Full Text] [Related]
6. Clinical and metabolic features of the randomised controlled Diabetes Remission Clinical Trial (DiRECT) cohort.
Taylor R; Leslie WS; Barnes AC; Brosnahan N; Thom G; McCombie L; Sattar N; Welsh P; Peters C; Zhyzhneuskaya S; Hollingsworth KG; Al-Mrabeh A; Rodrigues AM; Rehackova L; Adamson AJ; Sniehotta FF; Mathers JC; Ross HM; McIlvenna Y; Kean S; Ford I; McConnachie A; Lean MEJ
Diabetologia; 2018 Mar; 61(3):589-598. PubMed ID: 29188339
[TBL] [Abstract][Full Text] [Related]
7. Use of professional-mode flash glucose monitoring, at 3-month intervals, in adults with type 2 diabetes in general practice (GP-OSMOTIC): a pragmatic, open-label, 12-month, randomised controlled trial.
Furler J; O'Neal D; Speight J; Blackberry I; Manski-Nankervis JA; Thuraisingam S; de La Rue K; Ginnivan L; Doyle R; Holmes-Truscott E; Khunti K; Dalziel K; Chiang J; Audehm R; Kennedy M; Clark M; Jenkins A; Lake AJ; Januszewski AS; Catchpool M; Liew D; Clarke P; Best J
Lancet Diabetes Endocrinol; 2020 Jan; 8(1):17-26. PubMed ID: 31862147
[TBL] [Abstract][Full Text] [Related]
8. Tackling obesity in areas of high social deprivation: clinical effectiveness and cost-effectiveness of a task-based weight management group programme - a randomised controlled trial and economic evaluation.
McRobbie H; Hajek P; Peerbux S; Kahan BC; Eldridge S; Trépel D; Parrott S; Griffiths C; Snuggs S; Myers Smith K
Health Technol Assess; 2016 Oct; 20(79):1-150. PubMed ID: 27802843
[TBL] [Abstract][Full Text] [Related]
9. 2-year remission of type 2 diabetes and pancreas morphology: a post-hoc analysis of the DiRECT open-label, cluster-randomised trial.
Al-Mrabeh A; Hollingsworth KG; Shaw JAM; McConnachie A; Sattar N; Lean MEJ; Taylor R
Lancet Diabetes Endocrinol; 2020 Dec; 8(12):939-948. PubMed ID: 33031736
[TBL] [Abstract][Full Text] [Related]
10. Antihypertensive medication needs and blood pressure control with weight loss in the Diabetes Remission Clinical Trial (DiRECT).
Leslie WS; Ali E; Harris L; Messow CM; Brosnahan NT; Thom G; McCombie EL; Barnes AC; Sattar N; Taylor R; Lean MEJ
Diabetologia; 2021 Sep; 64(9):1927-1938. PubMed ID: 34056684
[TBL] [Abstract][Full Text] [Related]
11. The Diabetes Remission Clinical Trial (DiRECT): protocol for a cluster randomised trial.
Leslie WS; Ford I; Sattar N; Hollingsworth KG; Adamson A; Sniehotta FF; McCombie L; Brosnahan N; Ross H; Mathers JC; Peters C; Thom G; Barnes A; Kean S; McIlvenna Y; Rodrigues A; Rehackova L; Zhyzhneuskaya S; Taylor R; Lean ME
BMC Fam Pract; 2016 Feb; 17():20. PubMed ID: 26879684
[TBL] [Abstract][Full Text] [Related]
12. Adding web-based behavioural support to exercise referral schemes for inactive adults with chronic health conditions: the e-coachER RCT.
Taylor AH; Taylor RS; Ingram WM; Anokye N; Dean S; Jolly K; Mutrie N; Lambert J; Yardley L; Greaves C; King J; McAdam C; Steele M; Price L; Streeter A; Charles N; Terry R; Webb D; Campbell J; Hughes L; Ainsworth B; Jones B; Jane B; Erwin J; Little P; Woolf A; Cavanagh C
Health Technol Assess; 2020 Nov; 24(63):1-106. PubMed ID: 33243368
[TBL] [Abstract][Full Text] [Related]
13. The community-based prevention of diabetes (ComPoD) study: a randomised, waiting list controlled trial of a voluntary sector-led diabetes prevention programme.
Smith JR; Greaves CJ; Thompson JL; Taylor RS; Jones M; Armstrong R; Moorlock S; Griffin A; Solomon-Moore E; Biddle MSY; Price L; Abraham C
Int J Behav Nutr Phys Act; 2019 Nov; 16(1):112. PubMed ID: 31771589
[TBL] [Abstract][Full Text] [Related]
14. Effects of 3 months of 10-h per-day time-restricted eating and 3 months of follow-up on bodyweight and cardiometabolic health in Danish individuals at high risk of type 2 diabetes: the RESET single-centre, parallel, superiority, open-label, randomised controlled trial.
Quist JS; Pedersen HE; Jensen MM; Clemmensen KKB; Bjerre N; Ekblond TS; Uldal S; Størling J; Wewer Albrechtsen NJ; Holst JJ; Torekov SS; Nyeland ME; Vistisen D; Jørgensen ME; Panda S; Brock C; Finlayson G; Blond MB; Færch K
Lancet Healthy Longev; 2024 May; 5(5):e314-e325. PubMed ID: 38588687
[TBL] [Abstract][Full Text] [Related]
15. Long-term effects of intensive multifactorial therapy in individuals with screen-detected type 2 diabetes in primary care: 10-year follow-up of the ADDITION-Europe cluster-randomised trial.
Griffin SJ; Rutten GEHM; Khunti K; Witte DR; Lauritzen T; Sharp SJ; Dalsgaard EM; Davies MJ; Irving GJ; Vos RC; Webb DR; Wareham NJ; Sandbæk A
Lancet Diabetes Endocrinol; 2019 Dec; 7(12):925-937. PubMed ID: 31748169
[TBL] [Abstract][Full Text] [Related]
16. An internet-based intervention with brief nurse support to manage obesity in primary care (POWeR+): a pragmatic, parallel-group, randomised controlled trial.
Little P; Stuart B; Hobbs FR; Kelly J; Smith ER; Bradbury KJ; Hughes S; Smith PW; Moore MV; Lean ME; Margetts BM; Byrne CD; Griffin S; Davoudianfar M; Hooper J; Yao G; Zhu S; Raftery J; Yardley L
Lancet Diabetes Endocrinol; 2016 Oct; 4(10):821-8. PubMed ID: 27474214
[TBL] [Abstract][Full Text] [Related]
17. Person-centred experiential therapy versus cognitive behavioural therapy delivered in the English Improving Access to Psychological Therapies service for the treatment of moderate or severe depression (PRaCTICED): a pragmatic, randomised, non-inferiority trial.
Barkham M; Saxon D; Hardy GE; Bradburn M; Galloway D; Wickramasekera N; Keetharuth AD; Bower P; King M; Elliott R; Gabriel L; Kellett S; Shaw S; Wilkinson T; Connell J; Harrison P; Ardern K; Bishop-Edwards L; Ashley K; Ohlsen S; Pilling S; Waller G; Brazier JE
Lancet Psychiatry; 2021 Jun; 8(6):487-499. PubMed ID: 34000240
[TBL] [Abstract][Full Text] [Related]
18. Diet or diet plus physical activity versus usual care in patients with newly diagnosed type 2 diabetes: the Early ACTID randomised controlled trial.
Andrews RC; Cooper AR; Montgomery AA; Norcross AJ; Peters TJ; Sharp DJ; Jackson N; Fitzsimons K; Bright J; Coulman K; England CY; Gorton J; McLenaghan A; Paxton E; Polet A; Thompson C; Dayan CM
Lancet; 2011 Jul; 378(9786):129-39. PubMed ID: 21705068
[TBL] [Abstract][Full Text] [Related]
19. Cognitive behavioural therapy for adults with dissociative seizures (CODES): a pragmatic, multicentre, randomised controlled trial.
Goldstein LH; Robinson EJ; Mellers JDC; Stone J; Carson A; Reuber M; Medford N; McCrone P; Murray J; Richardson MP; Pilecka I; Eastwood C; Moore M; Mosweu I; Perdue I; Landau S; Chalder T;
Lancet Psychiatry; 2020 Jun; 7(6):491-505. PubMed ID: 32445688
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
